A pilot study on hepatobiliary scintigraphy to monitor regional liver function in yttrium-90 radioembolization
暂无分享,去创建一个
T. Labeur | M. Lam | R. Bennink | M. Braat | H. D. Jong | S. V. D. Velden | Mike V. Scholten | Otto M. van | Delden
[1] M. Abecassis,et al. Outcomes of Surgical Resection after Radioembolization for Hepatocellular Carcinoma. , 2018, Journal of vascular and interventional radiology : JVIR.
[2] K. Boudjema,et al. Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma , 2017, European Journal of Nuclear Medicine and Molecular Imaging.
[3] D. Ganger,et al. Comparative study of post-transplant outcomes in hepatocellular carcinoma patients treated with chemoembolization or radioembolization. , 2017, European journal of radiology.
[4] M. A. van den Bosch,et al. Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients , 2017, EJNMMI Research.
[5] S. Francque,et al. Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on (99m)Tc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure? , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[6] M. A. van den Bosch,et al. 90Y Hepatic Radioembolization: An Update on Current Practice and Recent Developments , 2015, The Journal of Nuclear Medicine.
[7] B. Sangro,et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] O. V. van Delden,et al. Monitoring of Total and Regional Liver Function after SIRT , 2014, Front. Oncol..
[9] J. Ertle,et al. Hepatic volume changes after lobar selective internal radiation therapy (SIRT) of hepatocellular carcinoma. , 2014, Clinical radiology.
[10] M. Abecassis,et al. Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. , 2013, Journal of hepatology.
[11] M. A. van den Bosch,et al. Transarterial RAdioembolization versus ChemoEmbolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial , 2012, Trials.
[12] F. Forrer,et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[13] T. V. van Gulik,et al. 99mTc-Mebrofenin Hepatobiliary Scintigraphy with SPECT for the Assessment of Hepatic Function and Liver Functional Volume Before Partial Hepatectomy , 2010, Journal of Nuclear Medicine.
[14] D. Gouma,et al. Assessment of Future Remnant Liver Function Using Hepatobiliary Scintigraphy in Patients Undergoing Major Liver Resection , 2009, Journal of Gastrointestinal Surgery.
[15] D. Gouma,et al. Risk Assessment of Posthepatectomy Liver Failure Using Hepatobiliary Scintigraphy and CT Volumetry , 2007, Journal of Nuclear Medicine.
[16] S. Gulec,et al. Dosimetric techniques in 90Y-microsphere therapy of liver cancer: The MIRD equations for dose calculations. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[17] Roelof J Bennink,et al. Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] R. Volkmann,et al. Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteers , 1996, Nuclear medicine communications.